The TRIMendous role of TRIMs in virus-host interactions

Vaccines

Volumn 5, Issue 3, 2017, Pages

  van Tol, Sarah ^a   Hage, Adam ^a   Giraldo, Maria Isabel ^a   Bharaj, Preeti ^a   Rajsbaum, Ricardo ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

E3 ubiquitin ligase; Innate immunity; Tripartite motif (TRIM); Type I interferons; Ubiquitin; Unanchored polyubiquitin; Viral antagonism; Virus infection

Indexed keywords

CYTOKINE; INFLAMMASOME; INTERFERON; INTERLEUKIN 1BETA CONVERTING ENZYME; NUCLEOTIDE BINDING PROTEIN; POLYUBIQUITIN; REPRESSOR PROTEIN; TRIPARTITE MOTIF PROTEIN; UBIQUITIN PROTEIN LIGASE;

ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL CYCLE PROGRESSION; CYTOTOXIC T LYMPHOCYTE; DNA VIRUS; FLAVIVIRUS; GENE EXPRESSION; INNATE IMMUNITY; NONHUMAN; PARAMYXOVIRIDAE; RETROVIRIDAE; RNA VIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

EID: 85028727543     PISSN: None     EISSN: 2076393X     Source Type: Journal    
DOI: 10.3390/vaccines5030023     Document Type: Article

References (272)

1. Yau, R.; Rape, M. The increasing complexity of the ubiquitin code. Nat. Cell Biol. 2016, 18, 579-586.
2. Ebner, P.; Versteeg, G.A.; Ikeda, F. Ubiquitin enzymes in the regulation of immune responses. Crit. Rev. Biochem. Mol. Biol. 2017.
3. Husnjak, K.; Dikic, I. Ubiquitin-binding proteins: Decoders of ubiquitin-mediated cellular functions. Annu. Rev. Biochem. 2012, 81, 291-322.
4. Ye, Y.; Rape, M. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 2009, 10, 755-764.
5. Shi, Y.; Yuan, B.; Zhu, W.; Zhang, R.; Li, L.; Hao, X.; Chen, S.; Hou, F. Ube2d3 and ube2n are essential for RIG-I-mediated mavs aggregation in antiviral innate immunity. Nat. Commun. 2017, 8, 15138.
6. Rajsbaum, R.; Garcia-Sastre, A.; Versteeg, G.A. Trimmunity: The roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J. Mol. Biol. 2014, 426, 1265-1284.
7. Versteeg, G.A.; Benke, S.; Garcia-Sastre, A.; Rajsbaum, R. Intrimsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins. Cytokine Growth Factor Rev. 2014, 25, 563-576.
8. Ohtake, F.; Saeki, Y.; Sakamoto, K.; Ohtake, K.; Nishikawa, H.; Tsuchiya, H.; Ohta, T.; Tanaka, K.; Kanno, J. Ubiquitin acetylation inhibits polyubiquitin chain elongation. EMBO Rep. 2015, 16, 192-201.
9. Swatek, K.N.; Komander, D. Ubiquitin modifications. Cell Res. 2016, 26, 399-422.
10. Hicke, L.; Schubert, H.L.; Hill, C.P. Ubiquitin-binding domains. Nat. Rev. Mol. Cell Biol. 2005, 6, 610-621.
11. Rajsbaum, R.; Versteeg, G.A.; Schmid, S.; Maestre, A.M.; Belicha-Villanueva, A.; Martinez-Romero, C.; Patel, J.R.; Morrison, J.; Pisanelli, G.; Miorin, L.; et al. Unanchored k48-linked polyubiquitin synthesized by the e3-ubiquitin ligase TRIM6 stimulates the interferon-ikkepsilon kinase-mediated antiviral response. Immunity 2014, 40, 880-895.
12. Fletcher, A.J.; Mallery, D.L.; Watkinson, R.E.; Dickson, C.F.; James, L.C. Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21. Proc. Natl. Acad. Sci. USA 2015, 112, 10014-10019.
13. Ozato, K.; Shin, D.M.; Chang, T.H.; Morse, H.C., 3rd. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 2008, 8, 849-860.
14. Uchil, P.D.; Hinz, A.; Siegel, S.; Coenen-Stass, A.; Pertel, T.; Luban, J.; Mothes, W. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J. Virol. 2013, 87, 257-272.
15. Uchil, P.D.; Quinlan, B.D.; Chan, W.T.; Luna, J.M.; Mothes, W. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 2008, 4, e16.
16. Versteeg, G.A.; Rajsbaum, R.; Sanchez-Aparicio, M.T.; Maestre, A.M.; Valdiviezo, J.; Shi, M.; Inn, K.S.; Fernandez-Sesma, A.; Jung, J.; Garcia-Sastre, A. The E3-ligase trim family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 2013, 38, 384-398.
17. Esposito, D.; Koliopoulos, M.G.; Rittinger, K. Structural determinants of TRIM protein function. Biochem. Soc. Trans. 2017, 45, 183-191.
18. Reymond, A.; Meroni, G.; Fantozzi, A.; Merla, G.; Cairo, S.; Luzi, L.; Riganelli, D.; Zanaria, E.; Messali, S.; Cainarca, S.; et al. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20, 2140-2151.
19. Bell, J.L.; Malyukova, A.; Holien, J.K.; Koach, J.; Parker, M.W.; Kavallaris, M.; Marshall, G.M.; Cheung, B.B. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members. PLoS ONE 2012, 7, e37470.
20. Massiah, M.A.; Simmons, B.N.; Short, K.M.; Cox, T.C. Solution structure of the RBCC/TRIM B-box1 domain of human mid1: B-box with a ring. J. Mol. Biol. 2006, 358, 532-545.
21. Koliopoulos, M.G.; Esposito, D.; Christodoulou, E.; Taylor, I.A.; Rittinger, K. Functional role of TRIM E3 ligase oligomerization and regulation of catalytic activity. EMBO J. 2016, 35, 1204-1218.
22. Sanchez, J.G.; Okreglicka, K.; Chandrasekaran, V.; Welker, J.M.; Sundquist, W.I.; Pornillos, O. The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer. Proc. Natl. Acad. Sci. USA 2014, 111, 2494-2499.
23. Dawidziak, D.M.; Sanchez, J.G.; Wagner, J.M.; Ganser-Pornillos, B.K.; Pornillos, O. Structure and catalytic activation of the TRIM23 ring E3 ubiquitin ligase. Proteins 2017.
24. Li, Y.; Wu, H.; Wu, W.; Zhuo, W.; Liu, W.; Zhang, Y.; Cheng, M.; Chen, Y.G.; Gao, N.; Yu, H.; et al. Structural insights into the TRIM family of ubiquitin E3 ligases. Cell Res. 2014, 24, 762-765.
25. Weinert, C.; Morger, D.; Djekic, A.; Grutter, M.G.; Mittl, P.R. Crystal structure of TRIM20 c-terminal coiled-coil/b30.2 fragment: Implications for the recognition of higher order oligomers. Sci. Rep. 2015, 5, 10819.
26. Diaz-Griffero, F.; Qin, X.-r.; Hayashi, F.; Kigawa, T.; Finzi, A.; Sarnak, Z.; Lienlaf, M.; Yokoyama, S.; Sodroski, J. A b-box 2 surface patch important for TRIM5 self-association, capsid binding avidity, and retrovirus restriction. J. Virol. 2009, 83, 10737-10751.
27. Li, X.; Sodroski, J. The TRIM5alpha b-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association. J. Virol. 2008, 82, 11495-11502.
28. Streich, F.C., Jr.; Ronchi, V.P.; Connick, J.P.; Haas, A.L. Tripartite motif ligases catalyze polyubiquitin chain formation through a cooperative allosteric mechanism. J. Biol. Chem. 2013, 288, 8209-8221.
29. Yudina, Z.; Roa, A.; Johnson, R.; Biris, N.; de Souza Aranha Vieira, D.A.; Tsiperson, V.; Reszka, N.; Taylor, A.B.; Hart, P.J.; Demeler, B.; et al. Ring dimerization links higher-order assembly of TRIM5alpha to synthesis of k63-linked polyubiquitin. Cell Rep. 2015, 12, 788-797.
30. Zhou, Z.; Jia, X.; Xue, Q.; Dou, Z.; Ma, Y.; Zhao, Z.; Jiang, Z.; He, B.; Jin, Q.; Wang, J. TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-i-like receptor-mediated innate immune response. Proc. Natl. Acad. Sci. USA 2014, 111, E245-E254.
31. Short, K.M.; Cox, T.C. Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding. J. Biol. Chem. 2006, 281, 8970-8980.
32. Sardiello, M.; Cairo, S.; Fontanella, B.; Ballabio, A.; Meroni, G. Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol. Biol. 2008, 8, 225.
33. Shi, M.; Cho, H.; Inn, K.S.; Yang, A.; Zhao, Z.; Liang, Q.; Versteeg, G.A.; Amini-Bavil-Olyaee, S.; Wong, L.Y.; Zlokovic, B.V.; et al. Negative regulation of NF-B activity by brain-specific tripartite motif protein 9. Nat. Commun. 2014, 5, 4820.
34. Chikuma, S.; Suita, N.; Okazaki, I.M.; Shibayama, S.; Honjo, T. TRIM28 prevents autoinflammatory T cell development in vivo. Nat. Immunol. 2012, 13, 596-603.
35. Ichimura, T.; Taoka, M.; Shoji, I.; Kato, H.; Sato, T.; Hatakeyama, S.; Isobe, T.; Hachiya, N. 14-3-3 proteins sequester a pool of soluble TRIM32 ubiquitin ligase to repress autoubiquitylation and cytoplasmic body formation. J. Cell Sci. 2013, 126, 2014-2026.
36. Diaz-Griffero, F.; Li, X.; Javanbakht, H.; Song, B.; Welikala, S.; Stremlau, M.; Sodroski, J. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 2006, 349, 300-315.
37. Sugiura, T. The cellular level of TRIM31, an RBCC protein overexpressed in gastric cancer, is regulated by multiple mechanisms including the ubiquitin-proteasome system. Cell Biol. Int. 2011, 35, 657-661.
38. Meroni, G. Genomics and evolution of the trim gene family. Adv. Exp. Med. Biol. 2012, 770, 1-9.
39. Han, K.; Lou, D.I.; Sawyer, S.L. Identification of a genomic reservoir for new TRIM genes in primate genomes. PLoS Genet. 2011, 7, e1002388.
40. Boudinot, P.; van der Aa, L.M.; Jouneau, L.; Du Pasquier, L.; Pontarotti, P.; Briolat, V.; Benmansour, A.; Levraud, J.P. Origin and evolution of TRIM proteins: New insights from the complete trim repertoire of zebrafish and pufferfish. PLoS ONE 2011, 6, e22022.
41. Malfavon-Borja, R.; Sawyer, S.L.; Wu, L.I.; Emerman, M.; Malik, H.S. An evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene family. Genome Biol. Evol. 2013, 5, 2141-2154.
42. He, D.D.; Lu, Y.; Gittelman, R.; Jin, Y.; Ling, F.; Joshua, A. Positive selection of the TRIM family regulatory region in primate genomes. Proc. Biol. Sci. 2016.
43. Sawyer, S.L.; Emerman, M.; Malik, H.S. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 2007, 3, e197.
44. Sawyer, S.L.; Wu, L.I.; Emerman, M.; Malik, H.S. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. USA 2005, 102, 2832-2837.
45. Carthagena, L.; Bergamaschi, A.; Luna, J.M.; David, A.; Uchil, P.D.; Margottin-Goguet, F.; Mothes, W.; Hazan, U.; Transy, C.; Pancino, G.; et al. Human trim gene expression in response to interferons. PLoS ONE 2009, 4, e4894.
46. Gao, B.; Xu, W.; Wang, Y.; Zhong, L.; Xiong, S. Induction of TRIM22 by IFN-gamma involves jak and pc-plc/pkc, but not mapks and P13K/AKT/mtor pathways. J. Interferon Cytokine Res. 2013, 33, 578-587.
47. Sjostrand, M.; Ambrosi, A.; Brauner, S.; Sullivan, J.; Malin, S.; Kuchroo, V.K.; Espinosa, A.; Wahren-Herlenius, M. Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors. J. Immunol. 2013, 191, 3753-3763.
48. Rajsbaum, R.; Stoye, J.P.; O’Garra, A. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur. J. Immunol. 2008, 38, 619-630.
49. Hu, M.M.; Xie, X.Q.; Yang, Q.; Liao, C.Y.; Ye, W.; Lin, H.; Shu, H.B. TRIM38 negatively regulates TLR3/4-mediated innate immune and inflammatory responses by two sequential and distinct mechanisms. J. Immunol. 2015, 195, 4415-4425.
50. Narayan, K.; Waggoner, L.; Pham, S.T.; Hendricks, G.L.; Waggoner, S.N.; Conlon, J.; Wang, J.P.; Fitzgerald, K.A.; Kang, J. TRIM13 is a negative regulator of MDA5-mediated type I interferon production. J. Virol. 2014, 88, 10748-10757.
51. Jiang, M.X.; Hong, X.; Liao, B.B.; Shi, S.Z.; Lai, X.F.; Zheng, H.Y.; Xie, L.; Wang, Y.; Wang, X.L.; Xin, H.B.; et al. Expression profiling of TRIM protein family in thp1-derived macrophages following TLR stimulation. Sci. Rep. 2017, 7, 42781.
52. McNab, F.W.; Rajsbaum, R.; Stoye, J.P.; O’Garra, A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 2011, 23, 46-56.
53. Manocha, G.D.; Mishra, R.; Sharma, N.; Kumawat, K.L.; Basu, A.; Singh, S.K. Regulatory role of TRIM21 in the type-I interferon pathway in japanese encephalitis virus-infected human microglial cells. J. Neuroinflamm. 2014, 11, 24.
54. Laurent-Rolle, M.; Morrison, J.; Rajsbaum, R.; Macleod, J.M.; Pisanelli, G.; Pham, A.; Ayllon, J.; Miorin, L.; Martinez-Romero, C.; tenOever, B.R.; et al. The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. Cell Host Microbe 2014, 16, 314-327.
55. Manokaran, G.; Finol, E.; Wang, C.; Gunaratne, J.; Bahl, J.; Ong, E.Z.; Tan, H.C.; Sessions, O.M.; Ward, A.M.; Gubler, D.J.; et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 2015, 350, 217-221.
56. Bharaj, P.; Wang, Y.E.; Dawes, B.E.; Yun, T.E.; Park, A.; Yen, B.; Basler, C.F.; Freiberg, A.N.; Lee, B.; Rajsbaum, R. The matrix protein of nipah virus targets the E3-ubiquitin ligase TRIM6 to inhibit the ikkepsilon kinase-mediated type-I IFN antiviral response. PLoS Pathog. 2016, 12, e1005880.
57. Gack, M.U.; Albrecht, R.A.; Urano, T.; Inn, K.S.; Huang, I.C.; Carnero, E.; Farzan, M.; Inoue, S.; Jung, J.U.; Garcia-Sastre, A. Influenza a virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA Sensor RIG-I. Cell Host Microbe 2009, 5, 439-449.
58. Rajsbaum, R.; Garcia-Sastre, A. Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways. Trends Microbiol. 2013, 21, 421-429.
59. Hatakeyama, S. TRIM family proteins: Roles in autophagy, immunity, and carcinogenesis. Trends Biochem. Sci. 2017, 42, 297-311.
60. Kimura, T.; Mandell, M.; Deretic, V. Precision autophagy directed by receptor regulators--Emerging examples within the TRIM family. J. Cell Sci. 2016, 129, 881-891.
61. Watanabe, M.; Hatakeyama, S. TRIM proteins and diseases. J. Biochem. 2017, 161, 135-144.
62. Takeuchi, O.; Akira, S. Pattern recognition receptors and inflammation. Cell 2010, 140, 805-820.
63. Liu, S.; Chen, Z.J. Expanding role of ubiquitination in NF-b signaling. Cell Res. 2010, 21, 6-21.
64. Hiscott, J. Convergence of the NF-b and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 2007, 18, 483-490.
65. Runge, S.; Sparrer, K.M.; Lassig, C.; Hembach, K.; Baum, A.; Garcia-Sastre, A.; Soding, J.; Conzelmann, K.K.; Hopfner, K.P. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog. 2014, 10, e1004081.
66. Yoneyama, M.; Kikuchi, M.; Natsukawa, T.; Shinobu, N.; Imaizumi, T.; Miyagishi, M.; Taira, K.; Akira, S.; Fujita, T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5, 730-737.
67. Hornung, V.; Ellegast, J.; Kim, S.; Brzozka, K.; Jung, A.; Kato, H.; Poeck, H.; Akira, S.; Conzelmann, K.K.; Schlee, M.; et al. 5'-triphosphate rna is the ligand for RIG-I. Science 2006, 314, 994-997.
68. Pichlmair, A.; Schulz, O.; Tan, C.P.; Naslund, T.I.; Liljestrom, P.; Weber, F.; Reise Sousa, C. Rig-i-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314, 997-1001.
69. Kato, H.; Takeuchi, O.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Matsui, K.; Uematsu, S.; Jung, A.; Kawai, T.; Ishii, K.J.; et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441, 101-105.
70. Chan, Y.K.; Gack, M.U. RIG-I-like receptor regulation in virus infection and immunity. Curr. Opin. Virol. 2015, 12, 7-14.
71. Jiang, X.; Kinch, L.N.; Brautigam, C.A.; Chen, X.; Du, F.; Grishin, N.V.; Chen, Z.J. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36, 959-973.
72. Wu, B.; Peisley, A.; Richards, C.; Yao, H.; Zeng, X.; Lin, C.; Chu, F.; Walz, T.; Hur, S. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152, 276-289.
73. Seth, R.B.; Sun, L.; Ea, C.K.; Chen, Z.J. Identification and characterization of mavs, a mitochondrial antiviral signaling protein that activates NF-B and IRF 3. Cell 2005, 122, 669-682.
74. Peisley, A.; Wu, B.; Yao, H.; Walz, T.; Hur, S. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol. Cell 2013, 51, 573-583.
75. Gack, M.U.; Nistal-Villan, E.; Inn, K.S.; Garcia-Sastre, A.; Jung, J.U. Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J. Virol. 2010, 84, 3220-3229.
76. Oshiumi, H.; Miyashita, M.; Inoue, N.; Okabe, M.; Matsumoto, M.; Seya, T. The ubiquitin ligase riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 2010, 8, 496-509.
77. Zeng, W.; Sun, L.; Jiang, X.; Chen, X.; Hou, F.; Adhikari, A.; Xu, M.; Chen, Z.J. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141, 315-330.
78. Arimoto, K.; Takahashi, H.; Hishiki, T.; Konishi, H.; Fujita, T.; Shimotohno, K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl. Acad. Sci. USA 2007, 104, 7500-7505.
79. Arimoto, K.; Konishi, H.; Shimotohno, K. Ubch8 regulates ubiquitin and ISG15 conjugation to RIG-I. Mol. Immunol. 2008, 45, 1078-1084.
80. Hou, F.; Sun, L.; Zheng, H.; Skaug, B.; Jiang, Q.X.; Chen, Z.J. Mavs forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146, 448-461.
81. Liu, S.; Chen, J.; Cai, X.; Wu, J.; Chen, X.; Wu, Y.T.; Sun, L.; Chen, Z.J. Mavs recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife 2013, 2, e00785.
82. Xie, P. Traf molecules in cell signaling and in human diseases. J. Mol. Signal. 2013, 8, 7.
83. Deng, L.; Wang, C.; Spencer, E.; Yang, L.; Braun, A.; You, J.; Slaughter, C.; Pickart, C.; Chen, Z.J. Activation of the i b kinase complex by traf6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103, 351-361.
84. Kanayama, A.; Seth, R.B.; Sun, L.; Ea, C.K.; Hong, M.; Shaito, A.; Chiu, Y.H.; Deng, L.; Chen, Z.J. TAB2 and TAB3 activate the NF-B pathway through binding to polyubiquitin chains. Mol. Cell 2004, 15, 535-548.
85. Xia, Z.P.; Sun, L.; Chen, X.; Pineda, G.; Jiang, X.; Adhikari, A.; Zeng, W.; Chen, Z.J. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 2009, 461, 114-119.
86. Christian, F.; Smith, E.L.; Carmody, R.J. The regulation of NF-B subunits by phosphorylation. Cells 2016.
87. McNab, F.; Mayer-Barber, K.; Sher, A.; Wack, A.; O’Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 2015, 15, 87-103.
88. Chau, T.L.; Gioia, R.; Gatot, J.S.; Patrascu, F.; Carpentier, I.; Chapelle, J.P.; O’Neill, L.; Beyaert, R.; Piette, J.; Chariot, A. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem. Sci. 2008, 33, 171-180.
89. Juang, Y.T.; Lowther, W.; Kellum, M.; Au, W.C.; Lin, R.; Hiscott, J.; Pitha, P.M. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 1998, 95, 9837-9842.
90. Lang, X.; Tang, T.; Jin, T.; Ding, C.; Zhou, R.; Jiang, W. TRIM65-catalized ubiquitination is essential for MDA5-mediated antiviral innate immunity. J. Exp. Med. 2017, 214, 459-473.
91. Yan, J.; Li, Q.; Mao, A.P.; Hu, M.M.; Shu, H.B. TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for k63-linked ubiquitination. J. Mol. Cell Biol. 2014, 6, 154-163.
92. Gack, M.U.; Shin, Y.C.; Joo, C.H.; Urano, T.; Liang, C.; Sun, L.; Takeuchi, O.; Akira, S.; Chen, Z.; Inoue, S.; et al. TRIM25 ring-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446, 916-920.
93. Oshiumi, H.; Matsumoto, M.; Seya, T. Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J. Biochem. 2011, 151, 5-11.
94. Pauli, E.K.; Chan, Y.K.; Davis, M.E.; Gableske, S.; Wang, M.K.; Feister, K.F.; Gack, M.U. The ubiquitin-specific protease usp15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. Sci. Signal. 2014.
95. Hu, M.M.; Shu, H.B. Multifaceted roles of TRIM38 in innate immune and inflammatory responses. Cell Mol. Immunol. 2017, 14, 331-338.
96. Hu, M.M.; Liao, C.Y.; Yang, Q.; Xie, X.Q.; Shu, H.B. Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5. J. Exp. Med. 2017, 214, 973-989.
97. Kondo, T.; Watanabe, M.; Hatakeyama, S. TRIM59 interacts with ecsit and negatively regulates NF-B and IRF-3/7-mediated signal pathways. Biochem. Biophys. Res. Commun. 2012, 422, 501-507.
98. Xu, C.; Evensen, O.; Munang’andu, H.M. De novo transcriptome analysis shows that sav-3 infection upregulates pattern recognition receptors of the endosomal toll-like and RIG-I-like receptor signaling pathways in macrophage/dendritic like to-cells. Viruses 2016, 8, 114.
99. Miranzo-Navarro, D.; Magor, K.E. Activation of duck rig-i by TRIM25 is independent of anchored ubiquitin. PLoS ONE 2014, 9, e86968.
100. Rajsbaum, R.; Albrecht, R.A.; Wang, M.K.; Maharaj, N.P.; Versteeg, G.A.; Nistal-Villan, E.; Garcia-Sastre, A.; Gack, M.U. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza a virus ns1 protein. PLoS Pathog. 2012, 8, e1003059.
101. Feng, Z.Q.; Cheng, Y.; Yang, H.L.; Zhu, Q.; Yu, D.; Liu, Y.P. Molecular characterization, tissue distribution and expression analysis of TRIM25 in gallus gallus domesticus. Gene 2015, 561, 138-147.
102. Blaine, A.H.; Miranzo-Navarro, D.; Campbell, L.K.; Aldridge, J.R.; Webster, R.G.; Magor, K.E. Duck TRIM27-l enhances mavs signaling and is absent in chickens and turkeys. Mol. Immunol. 2015, 67, 607-615.
103. Castanier, C.; Zemirli, N.; Portier, A.; Garcin, D.; Bidere, N.; Vazquez, A.; Arnoult, D. Mavs ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors. BMC Biol. 2012, 10, 44.
104. Liu, B.; Zhang, M.; Chu, H.; Zhang, H.; Wu, H.; Song, G.; Wang, P.; Zhao, K.; Hou, J.; Wang, X.; et al. The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor mavs through lys63-linked polyubiquitination. Nat. Immunol. 2016, 18, 214-224.
105. Yang, B.; Wang, J.; Wang, Y.; Zhou, H.; Wu, X.; Tian, Z.; Sun, B. Novel function of TRIM44 promotes an antiviral response by stabilizing visa. J. Immunol. 2013, 190, 3613-3619.
106. Qin, Y.; Liu, Q.; Tian, S.; Xie, W.; Cui, J.; Wang, R.F. TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type i interferon by recruiting GSK3 to TBK1. Cell Res. 2016, 26, 613-628.
107. Zevini, A.; Olagnier, D.; Hiscott, J. Crosstalk between cytoplasmic RIG-I and sting sensing pathways. Trends Immunol. 2017, 38, 194-205.
108. Lee, Y.; Song, B.; Park, C.; Kwon, K.S. TRIM11 negatively regulates ifn production and antiviral activity by targeting TBK1. PLoS ONE 2013, 8, e63255.
109. Zhao, W.; Wang, L.; Zhang, M.; Wang, P.; Yuan, C.; Qi, J.; Meng, H.; Gao, C. Tripartite motif-containing protein 38 negatively regulates TLR3/4- and RIG-I-mediated IFN-production and antiviral response by targeting NAP1. J. Immunol. 2012, 188, 5311-5318.
110. Arimoto, K.; Funami, K.; Saeki, Y.; Tanaka, K.; Okawa, K.; Takeuchi, O.; Akira, S.; Murakami, Y.; Shimotohno, K. Polyubiquitin conjugation to nemo by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc. Natl. Acad. Sci. USA 2010, 107, 15856-15861.
111. Ran, Y.; Zhang, J.; Liu, L.L.; Pan, Z.Y.; Nie, Y.; Zhang, H.Y.; Wang, Y.Y. Autoubiquitination of TRIM26 links TBK1 to nemo in RLR-mediated innate antiviral immune response. J. Mol. Cell Biol. 2015, 8, 31-43.
112. Wynne, C.; Lazzari, E.; Smith, S.; McCarthy, E.M.; Ni Gabhann, J.; Kallal, L.E.; Higgs, R.; Greco, A.; Cryan, S.A.; Biron, C.A.; et al. TRIM68 negatively regulates IFN-production by degrading TRK fused gene, a novel driver of IFN-downstream of anti-viral detection systems. PLoS ONE 2014, 9, e101503.
113. Shi, M.; Deng, W.; Bi, E.; Mao, K.; Ji, Y.; Lin, G.; Wu, X.; Tao, Z.; Li, Z.; Cai, X.; et al. Trim30 negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 2008, 9, 369-377.
114. Yuan, T.; Yao, W.; Huang, F.; Sun, B.; Yang, R. The human antiviral factor TRIM11 is under the regulation of HIV-1 VPR. PLoS ONE 2014, 9, e104269.
115. Xing, J.; Weng, L.; Yuan, B.; Wang, Z.; Jia, L.; Jin, R.; Lu, H.; Li, X.C.; Liu, Y.J.; Zhang, Z. Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. Nat. Immunol. 2016, 17, 1373-1380.
116. Suzuki, M.; Watanabe, M.; Nakamaru, Y.; Takagi, D.; Takahashi, H.; Fukuda, S.; Hatakeyama, S. TRIM39 negatively regulates the NF B-mediated signaling pathway through stabilization of cactin. Cell Mol. Life Sci. 2015, 73, 1085-1101.
117. Ishikawa, H.; Barber, G.N. Sting is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455, 674-678.
118. Ishikawa, H.; Ma, Z.; Barber, G.N. Sting regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461, 788-792.
119. Burdette, D.L.; Monroe, K.M.; Sotelo-Troha, K.; Iwig, J.S.; Eckert, B.; Hyodo, M.; Hayakawa, Y.; Vance, R.E. Sting is a direct innate immune sensor of cyclic di-gmp. Nature 2011, 478, 515-518.
120. Shu, C.; Yi, G.; Watts, T.; Kao, C.C.; Li, P. Structure of sting bound to cyclic di-gmp reveals the mechanism of cyclic dinucleotide recognition by the immune system. Nat. Struct. Mol. Biol. 2012, 19, 722-724.
121. Omura, H.; Oikawa, D.; Nakane, T.; Kato, M.; Ishii, R.; Ishitani, R.; Tokunaga, F.; Nureki, O. Structural and functional analysis of ddx41: A bispecific immune receptor for DNA and cyclic dinucleotide. Sci. Rep. 2016, 6, 34756.
122. Parvatiyar, K.; Zhang, Z.; Teles, R.M.; Ouyang, S.; Jiang, Y.; Iyer, S.S.; Zaver, S.A.; Schenk, M.; Zeng, S.; Zhong, W.; et al. The helicase ddx41 recognizes the bacterial secondary messengers cyclic di-gmp and cyclic di-amp to activate a type I interferon immune response. Nat. Immunol. 2012, 13, 1155-1161.
123. Zhang, Z.; Bao, M.; Lu, N.; Weng, L.; Yuan, B.; Liu, Y.J. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat. Immunol. 2012, 14, 172-178.
124. Wang, Y.; Lian, Q.; Yang, B.; Yan, S.; Zhou, H.; He, L.; Lin, G.; Lian, Z.; Jiang, Z.; Sun, B. TRIM30 is a negative-feedback regulator of the intracellular DNA and DNA virus-triggered response by targeting sting. PLoS Pathog. 2015, 11, e1005012.
125. Tsuchida, T.; Zou, J.; Saitoh, T.; Kumar, H.; Abe, T.; Matsuura, Y.; Kawai, T.; Akira, S. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 2010, 33, 765-776.
126. Zhang, J.; Hu, M.M.; Wang, Y.Y.; Shu, H.B. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting mita/sting protein for k63-linked ubiquitination. J. Biol. Chem. 2012, 287, 28646-28655.
127. Jimenez-Dalmaroni, M.J.; Gerswhin, M.E.; Adamopoulos, I.E. The critical role of toll-like receptors-from microbial recognition to autoimmunity: A comprehensive review. Autoimmun. Rev. 2015, 15, 1-8.
128. Higgs, R.; Ni Gabhann, J.; Ben Larbi, N.; Breen, E.P.; Fitzgerald, K.A.; Jefferies, C.A. The E3 ubiquitin ligase ro52 negatively regulates IFN-production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 2008, 181, 1780-1786.
129. Higgs, R.; Lazzari, E.; Wynne, C.; Ni Gabhann, J.; Espinosa, A.; Wahren-Herlenius, M.; Jefferies, C.A. Self protection from anti-viral responses-ro52 promotes degradation of the transcription factor IRF7 downstream of the viral toll-like receptors. PLoS ONE 2010, 5, e11776.
130. Lazzari, E.; Korczeniewska, J.; Ni Gabhann, J.; Smith, S.; Barnes, B.J.; Jefferies, C.A. Tripartite motif 21 (TRIM21) differentially regulates the stability of interferon regulatory factor 5 (IRF5) isoforms. PLoS ONE 2014, 9, e103609.
131. Zhao, W.; Wang, L.; Zhang, M.; Yuan, C.; Gao, C. E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages. J. Immunol. 2012, 188, 2567-2574.
132. Xue, Q.; Zhou, Z.; Lei, X.; Liu, X.; He, B.; Wang, J.; Hung, T. TRIM38 negatively regulates TLR3-mediated IFN-signaling by targeting trif for degradation. PLoS ONE 2012, 7, e46825.
133. Shen, Y.; Li, N.L.; Wang, J.; Liu, B.; Lester, S.; Li, K. TRIM56 is an essential component of the TLR3 antiviral signaling pathway. J. Biol. Chem. 2012, 287, 36404-36413.
134. Lamkanfi, M.; Dixit, V.M. Mechanisms and functions of inflammasomes. Cell 2014, 157, 1013-1022.
135. Latz, E.; Xiao, T.S.; Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 2013, 13, 397-411.
136. Kapoor, A.; Forman, M.; Arav-Boger, R. Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication. PLoS ONE 2014, 9, e92704.
137. Moreira, L.O.; Zamboni, D.S. NOD1 and NOD2 signaling in infection and inflammation. Front. Immunol. 2012, 3, 328.
138. Weng, L.; Mitoma, H.; Trichot, C.; Bao, M.; Liu, Y.; Zhang, Z.; Liu, Y.J. The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation. J. Immunol. 2014, 193, 3676-3682.
139. Hu, Y.; Mao, K.; Zeng, Y.; Chen, S.; Tao, Z.; Yang, C.; Sun, S.; Wu, X.; Meng, G.; Sun, B. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production. J. Immunol. 2010, 185, 7699-7705.
140. Song, H.; Liu, B.; Huai, W.; Yu, Z.; Wang, W.; Zhao, J.; Han, L.; Jiang, G.; Zhang, L.; Gao, C.; et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat. Commun. 2016, 7, 13727.
141. Zurek, B.; Schoultz, I.; Neerincx, A.; Napolitano, L.M.; Birkner, K.; Bennek, E.; Sellge, G.; Lerm, M.; Meroni, G.; Soderholm, J.D.; et al. TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation. PLoS ONE 2012, 7, e41255.
142. Tomar, D.; Sripada, L.; Prajapati, P.; Singh, R.; Singh, A.K. Nucleo-cytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NF-B pathway. PLoS ONE 2012, 7, e48662.
143. Okumura, F.; Matsunaga, Y.; Katayama, Y.; Nakayama, K.I.; Hatakeyama, S. TRIM8 modulates STAT3 activity through negative regulation of PIAS3. J. Cell Sci. 2010, 123, 2238-2245.
144. Hu, M.M.; Yang, Q.; Zhang, J.; Liu, S.M.; Zhang, Y.; Lin, H.; Huang, Z.F.; Wang, Y.Y.; Zhang, X.D.; Zhong, B.; et al. TRIM38 inhibits TNF - and IL-1-triggered NF-B activation by mediating lysosome-dependent degradation of TAB2/3. Proc. Natl. Acad. Sci. USA 2014, 111, 1509-1514.
145. Zheng, Q.; Hou, J.; Zhou, Y.; Yang, Y.; Xie, B.; Cao, X. Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27. Cell Res. 2015, 25, 1121-1136.
146. Wang, Y.; Li, J.; Huang, Y.; Dai, X.; Liu, Y.; Liu, Z.; Wang, N.; Zhang, P. Tripartite motif-containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR-1 and -2 and VEGFR2 in endothelial cells. FASEB J. 2017, 31, 2026-2036.
147. Fensterl, V.; Sen, G.C. Interferons and viral infections. Biofactors 2009, 35, 14-20.
148. Tisserand, J.; Khetchoumian, K.; Thibault, C.; Dembele, D.; Chambon, P.; Losson, R. Tripartite motif 24 (TRIM24/TIF1) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor (RAR) inhibition. J. Biol. Chem. 2011, 286, 33369-33379.
149. Toniato, E.; Chen, X.P.; Losman, J.; Flati, V.; Donahue, L.; Rothman, P. TRIM8/gerp ring finger protein interacts with socs-1. J. Biol. Chem. 2002, 277, 37315-37322.
150. Tenoever, B.R.; Ng, S.L.; Chua, M.A.; McWhirter, S.M.; Garcia-Sastre, A.; Maniatis, T. Multiple functions of the IKK-related kinase ikkepsilon in interferon-mediated antiviral immunity. Science 2007, 315, 1274-1278.
151. Ng, S.L.; Friedman, B.A.; Schmid, S.; Gertz, J.; Myers, R.M.; Tenoever, B.R.; Maniatis, T. I b kinase " (IKK”) regulates the balance between type I and type II interferon responses. Proc. Natl. Acad. Sci. USA 2011, 108, 21170-21175.
152. Oteiza, A.; Mechti, N. Control of foxo4 activity and cell survival by TRIM22 directs TLR3-stimulated cells toward IFN type I gene induction or apoptosis. J. Interferon Cytokine Res. 2015, 35, 859-874.
153. Gongora, C.; Tissot, C.; Cerdan, C.; Mechti, N. The interferon-inducible STAF50 gene is downregulated during T cell costimulation by CD2 and CD28. J. Interferon Cytokine Res. 2000, 20, 955-961.
154. Obad, S.; Olofsson, T.; Mechti, N.; Gullberg, U.; Drott, K. Regulation of the interferon-inducible p53 target gene TRIM22 (STAF50) in human T lymphocyte activation. J. Interferon Cytokine Res. 2007, 27, 857-864.
155. Perez-Lloret, J.; Okoye, I.S.; Guidi, R.; Kannan, Y.; Coomes, S.M.; Czieso, S.; Mengus, G.; Davidson, I.; Wilson, M.S. T-cell-intrinsic TIF1 /TRIM24 regulates IL-1r expression on Th2 cells and Th2 cell-mediated airway allergy. Proc. Natl. Acad. Sci. USA 2016, 113, E568-E576.
156. Cai, X.; Srivastava, S.; Sun, Y.; Li, Z.; Wu, H.; Zuvela-Jelaska, L.; Li, J.; Salamon, R.S.; Backer, J.M.; Skolnik, E.Y. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II P13K-c2. Proc. Natl. Acad. Sci. USA 2011, 108, 20072-20077.
157. Choi, U.Y.; Hur, J.Y.; Lee, M.S.; Zhang, Q.; Choi, W.Y.; Kim, L.K.; Lee, W.B.; Oh, G.T.; Kim, Y.J. Tripartite motif-containing protein 30 modulates TCR-activated proliferation and effector functions in CD4+ T cells. PLoS ONE 2014, 9, e95805.
158. Stremlau, M.; Owens, C.M.; Perron, M.J.; Kiessling, M.; Autissier, P.; Sodroski, J. The cytoplasmic body component TRIM5 restricts HIV-1 infection in old world monkeys. Nature 2004, 427, 848-853.
159. Yap, M.W.; Nisole, S.; Lynch, C.; Stoye, J.P. TRIM5 protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. USA 2004, 101, 10786-10791.
160. Nisole, S.; Lynch, C.; Stoye, J.P.; Yap, M.W. A TRIM5-cyclophilin a fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl. Acad. Sci. USA 2004, 101, 13324-13328.
161. Sayah, D.M.; Sokolskaja, E.; Berthoux, L.; Luban, J. Cyclophilin a retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430, 569.
162. Fletcher, A.J.; Christensen, D.E.; Nelson, C.; Tan, C.P.; Schaller, T.; Lehner, P.J.; Sundquist, W.I.; Towers, G.J. TRIM5 requires ube2w to anchor Lys63-linked ubiquitin chains and restrict reverse transcription. EMBO J. 2015, 34, 2078-2095.
163. Lamichhane, R.; Mukherjee, S.; Smolin, N.; Pauszek, R.F.; Bradley, M.; Sastri, J.; Robia, S.L.; Millar, D.; Campbell, E.M. Dynamic conformational changes in the rhesus TRIM5 dimer dictate the potency of HIV-1 restriction. Virology 2017, 500, 161-168.
164. Li, Y.-L.; Chandrasekaran, V.; Carter, S.D.; Woodward, C.L.; Christensen, D.E.; Dryden, K.A.; Pornillos, O.; Yeager, M.; Ganser-Pornillos, B.K.; Jensen, G.J. Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids. Elife 2016, 5, e16269.
165. Wagner, J.M.; Roganowicz, M.D.; Skorupka, K.; Alam, S.L.; Christensen, D.; Doss, G.; Wan, Y.; Frank, G.A.; Ganser-Pornillos, B.K.; Sundquist, W.I. Mechanism of B-box 2 domain-mediated higher-order assembly of the retroviral restriction factor TRIM5. Elife 2016, 5, e16309.
166. Keown, J.R.; Goldstone, D.C. Crystal structure of the TRIM5 bbox2 domain from rhesus macaques describes a plastic oligomerisation interface. J. Struct. Biol. 2016, 195, 282-285.
167. Sastri, J.; Campbell, E.M. Recent insights into the mechanism and consequences of TRIM5 retroviral restriction. AIDS Res. Hum. Retroviruses 2011, 27, 231-238.
168. Ganser-Pornillos, B.K.; Chandrasekaran, V.; Pornillos, O.; Sodroski, J.G.; Sundquist, W.I.; Yeager, M. Hexagonal assembly of a restricting TRIM5 protein. Proc. Natl. Acad. Sci. USA 2011, 108, 534-539.
169. Pertel, T.; Hausmann, S.; Morger, D.; Züger, S.; Guerra, J.; Lascano, J.; Reinhard, C.; Santoni, F.A.; Uchil, P.D.; Chatel, L. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472, 361-365.
170. Anderson, J.L.; Campbell, E.M.; Wu, X.; Vandegraaff, N.; Engelman, A.; Hope, T.J. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J. Virol. 2006, 80, 9754-9760.
171. Wu, X.; Anderson, J.L.; Campbell, E.M.; Joseph, A.M.; Hope, T.J. Proteasome inhibitors uncouple rhesus TRIM5 restriction of HIV-1 reverse transcription and infection. Proc. Natl. Acad. Sci. USA 2006, 103, 7465-7470.
172. Kutluay, S.B.; Perez-Caballero, D.; Bieniasz, P.D. Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathog. 2013, 9, e1003214.
173. Rold, C.J.; Aiken, C. Proteasomal degradation of TRIM5 during retrovirus restriction. PLoS Pathog. 2008, 4, e1000074.
174. Jimenez-Moyano, E.; Ruiz, A.; Kløverpris, H.N.; Rodriguez-Plata, M.T.; Peña, R.; Blondeau, C.; Selwood, D.L.; Izquierdo-Useros, N.; Moris, A.; Clotet, B. Nonhuman TRIM5 variants enhance recognition of HIV-1-infected cells by CD8+ T cells. J. Virol. 2016, 90, 8552-8562.
175. Sanz-Ramos, M.; Stoye, J.P. Capsid-binding retrovirus restriction factors: Discovery, restriction specificity and implications for the development of novel therapeutics. J. Gen. Virol. 2013, 94, 2587-2598.
176. Grütter, M.G.; Luban, J. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling. Curr. Opin. Virol. 2012, 2, 142-150.
177. Campbell, E.M.; Weingart, J.; Sette, P.; Opp, S.; Sastri, J.; O’Connor, S.K.; Talley, S.; Diaz-Griffero, F.; Hirsch, V.; Bouamr, F. TRIM5-mediated ubiquitin chain conjugation is required for inhibition of HIV-1 reverse transcription and capsid destabilization. J. Virol. 2016, 90, 1849-1857.
178. Lascano, J.; Uchil, P.D.; Mothes, W.; Luban, J. TRIM5 retroviral restriction activity correlates with the ability to induce innate immune signaling. J. Virol. 2016, 90, 308-316.
179. Wu, F.; Ourmanov, I.; Riddick, N.; Matsuda, K.; Whitted, S.; Plishka, R.J.; Buckler-White, A.; Starost, M.F.; Hirsch, V.M. TRIM5 restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques. J. Virol. 2015, 89, 2233-2240.
180. Letvin, N.L.; Mascola, J.R.; Sun, Y.; Gorgone, D.A.; Buzby, A.P.; Xu, L.; Yang, Z.-y.; Chakrabarti, B.; Rao, S.S.; Schmitz, J.E. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006, 312, 1530-1533.
181. Sun, J.C.; Bevan, M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003, 300, 339-342.
182. Shedlock, D.J.; Shen, H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003, 300, 337-339.
183. Yap, M.W.; Nisole, S.; Stoye, J.P. A single amino acid change in the spry domain of human TRIM5 leads to HIV-1 restriction. Curr. Biol. 2005, 15, 73-78.
184. Si, Z.; Vandegraaff, N.; O’Huigin, C.; Song, B.; Yuan, W.; Xu, C.; Perron, M.; Li, X.; Marasco, W.A.; Engelman, A.; et al. Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc. Natl. Acad. Sci. USA 2006, 103, 7454-7459.
185. Ylinen, L.M.; Keckesova, Z.; Webb, B.L.; Gifford, R.J.; Smith, T.P.; Towers, G.J. Isolation of an active lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. J. Virol. 2006, 80, 7332-7338.
186. Jauregui, P.; Crespo, H.; Glaria, I.; Lujan, L.; Contreras, A.; Rosati, S.; de Andres, D.; Amorena, B.; Towers, G.J.; Reina, R. Ovine TRIM5 can restrict visna/maedi virus. J. Virol. 2012, 86, 9504-9509.
187. Ribeiro, C.M.; Sarrami-Forooshani, R.; Setiawan, L.C.; Zijlstra-Willems, E.M.; van Hamme, J.L.; Tigchelaar, W.; van der Wel, N.N.; Kootstra, N.A.; Gringhuis, S.I.; Geijtenbeek, T.B. Receptor usage dictates HIV-1 restriction by human TRIM5 in dendritic cell subsets. Nature 2016, 540, 448-452.
188. Arhel, N.J.; Nisole, S.; Carthagena, L.; Coutant, F.; Souque, P.; Brussel, A.; Estaquier, J.; Charneau, P. Lack of endogenous TRIM5-mediated restriction in rhesus macaque dendritic cells. Blood 2008, 112, 3772-3776.
189. Portilho, D.M.; Fernandez, J.; Ringeard, M.; Machado, A.K.; Boulay, A.; Mayer, M.; Müller-Trutwin, M.; Beignon, A.-S.; Kirchhoff, F.; Nisole, S. Endogenous TRIM5 function is regulated by sumoylation and nuclear sequestration for efficient innate sensing in dendritic cells. Cell Rep. 2016, 14, 355-369.
190. Yuan, T.; Yao, W.; Tokunaga, K.; Yang, R.; Sun, B. An HIV-1 capsid binding protein TRIM11 accelerates viral uncoating. Retrovirology 2016, 13, 72.
191. Pawlica, P.; Le Sage, V.; Poccardi, N.; Tremblay, M.J.; Mouland, A.J.; Berthoux, L. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5-mediated restriction of retroviruses. J. Virol. 2014, 88, 5661-5676.
192. Banerjee, I.; Miyake, Y.; Nobs, S.P.; Schneider, C.; Horvath, P.; Kopf, M.; Matthias, P.; Helenius, A.; Yamauchi, Y. Influenza a virus uses the aggresome processing machinery for host cell entry. Science 2014, 346, 473-477.
193. Lukic, Z.; Dharan, A.; Fricke, T.; Diaz-Griffero, F.; Campbell, E.M. HIV-1 uncoating is facilitated by dynein and kinesin 1. J. Virol. 2014, 88, 13613-13625.
194. Pawlica, P.; Berthoux, L. Cytoplasmic dynein promotes HIV-1 uncoating. Viruses 2014, 6, 4195-4211.
195. Rajsbaum, R.; Garcia-Sastre, A. Virology. Unanchored ubiquitin in virus uncoating. Science 2014, 346, 427-428.
196. Suzuki, M.; Hara, Y.; Takagi, C.; Yamamoto, T.S.; Ueno, N. MID1 and MID2 are required for xenopus neural tube closure through the regulation of microtubule organization. Development 2010, 137, 2329-2339.
197. Turrini, F.; Marelli, S.; Kajaste-Rudnitski, A.; Lusic, M.; Lint, C.; Das, A.T.; Harwig, A.; Berkhout, B.; Vicenzi, E. HIV-1 transcriptional silencing caused by TRIM22 inhibition of sp1 binding to the viral promoter. Retrovirology 2015, 12, 104.
198. Tabah, A.A.; Tardif, K.; Mansky, L.M. Anti-HIV-1 activity of TRIM 37. J. Gen. Virol. 2014, 95, 960-967.
199. Masroori, N.; Merindol, N.; Berthoux, L. The interferon-induced antiviral protein pml (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion. Retrovirology 2016, 13, 19.
200. Kahle, T.; Volkmann, B.; Eissmann, K.; Herrmann, A.; Schmitt, S.; Wittmann, S.; Merkel, L.; Reuter, N.; Stamminger, T.; Gramberg, T. TRIM19/pml restricts HIV infection in a cell type-dependent manner. Viruses 2015, 8, 2.
201. Dutrieux, J.; Maarifi, G.; Portilho, D.M.; Arhel, N.J.; Chelbi-Alix, M.K.; Nisole, S. Pml/TRIM19-dependent inhibition of retroviral reverse-transcription by daxx. PLoS Pathog. 2015, 11, e1005280.
202. Bidgood, S.R.; Tam, J.C.; McEwan, W.A.; Mallery, D.L.; James, L.C. Translocalized IGA mediates neutralization and stimulates innate immunity inside infected cells. Proc. Natl. Acad. Sci. USA 2014, 111, 13463-13468.
203. Mallery, D.L.; McEwan, W.A.; Bidgood, S.R.; Towers, G.J.; Johnson, C.M.; James, L.C. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc. Natl. Acad. Sci. USA 2010, 107, 19985-19990.
204. Keeble, A.H.; Khan, Z.; Forster, A.; James, L.C. TRIM21 is an igg receptor that is structurally, thermodynamically, and kinetically conserved. Proc. Natl. Acad. Sci. USA 2008, 105, 6045-6050.
205. McEwan, W.A.; Tam, J.C.; Watkinson, R.E.; Bidgood, S.R.; Mallery, D.L.; James, L.C. Intracellular antibody-bound pathogens stimulate immune signaling via the fc receptor TRIM21. Nat. Immunol. 2013, 14, 327-336.
206. Watkinson, R.E.; Tam, J.C.; Vaysburd, M.J.; James, L.C. Simultaneous neutralization and innate immune detection of a replicating virus by TRIM21. J. Virol. 2013, 87, 7309-7313.
207. Watkinson, R.E.; McEwan, W.A.; Tam, J.C.; Vaysburd, M.; James, L.C. TRIM21 promotes cgas and RIG-I sensing of viral genomes during infection by antibody-opsonized virus. PLoS Pathog. 2015, 11, e1005253.
208. Foss, S.; Watkinson, R.E.; Grevys, A.; McAdam, M.B.; Bern, M.; Hoydahl, L.S.; Dalhus, B.; Michaelsen, T.E.; Sandlie, I.; James, L.C.; et al. TRIM21 immune signaling is more sensitive to antibody affinity than its neutralization activity. J. Immunol. 2016, 196, 3452-3459.
209. Vaysburd, M.; Watkinson, R.E.; Cooper, H.; Reed, M.; O’Connell, K.; Smith, J.; Cruickshanks, J.; James, L.C. Intracellular antibody receptor TRIM21 prevents fatal viral infection. Proc. Natl. Acad. Sci. USA 2013, 110, 12397-12401.
210. Fan, W.; Zhang, D.; Qian, P.; Qian, S.; Wu, M.; Chen, H.; Li, X. Swine TRIM21 restricts fmdv infection via an intracellular neutralization mechanism. Antiviral Res. 2016, 127, 32-40.
211. Jiang, J.; Li, J.; Fan, W.; Zheng, W.; Yu, M.; Chen, C.; Sun, L.; Bi, Y.; Ding, C.; Gao, G.F. Robust lys63-linked ubiquitination of RIG-I promotes cytokine eruption in early influenza b virus infection. J. Virol. 2016, 90, 6263-6275.
212. Di Pietro, A.; Kajaste-Rudnitski, A.; Oteiza, A.; Nicora, L.; Towers, G.J.; Mechti, N.; Vicenzi, E. TRIM22 inhibits influenza a virus infection by targeting the viral nucleoprotein for degradation. J. Virol. 2013, 87, 4523-4533.
213. Pflug, A.; Guilligay, D.; Reich, S.; Cusack, S. Structure of influenza a polymerase bound to the viral RNA promoter. Nature 2014, 516, 355-360.
214. Fu, B.; Wang, L.; Ding, H.; Schwamborn, J.C.; Li, S.; Dorf, M.E. TRIM32 senses and restricts influenza a virus by ubiquitination of pb1 polymerase. PLoS Pathog. 2015, 11, e1004960.
215. Liu, B.; Li, N.L.; Shen, Y.; Bao, X.; Fabrizio, T.; Elbahesh, H.; Webby, R.J.; Li, K. The C-terminal tail of TRIM56 dictates antiviral restriction of influenza A and B viruses by impeding viral RNA synthesis. J. Virol. 2016, 90, 4369-4382.
216. Holbrook, M.R. Historical perspectives on flavivirus research. Viruses 2017.
217. Fernandez-Garcia, M.D.; Mazzon, M.; Jacobs, M.; Amara, A. Pathogenesis of flavivirus infections: Using and abusing the host cell. Cell Host Microbe 2009, 5, 318-328.
218. Qashqari, H.; Al-Mars, A.; Chaudhary, A.; Abuzenadah, A.; Damanhouri, G.; Alqahtani, M.; Mahmoud, M.; El Sayed Zaki, M.; Fatima, K.; Qadri, I. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance. Infect. Genet. Evol. 2013, 19, 113-119.
219. Enomoto, N.; Sakuma, I.; Asahina, Y.; Kurosaki, M.; Murakami, T.; Yamamoto, C.; Ogura, Y.; Izumi, N.; Marumo, F.; Sato, C. Mutations in the nonstructural protein 5a gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 1996, 334, 77-81.
220. Wang, S.; Chen, Y.; Li, C.; Wu, Y.; Guo, L.; Peng, C.; Huang, Y.; Cheng, G.; Qin, F.X. TRIM14 inhibits hepatitis C virus infection by spry domain-dependent targeted degradation of the viral NS5a protein. Sci. Rep. 2016, 6, 32336.
221. Yang, C.; Zhao, X.; Sun, D.; Yang, L.; Chong, C.; Pan, Y.; Chi, X.; Gao, Y.; Wang, M.; Shi, X.; et al. Interferon (ifn)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5a. Cell Mol. Immunol. 2016, 13, 94-102.
222. Fan, W.; Wu, M.; Qian, S.; Zhou, Y.; Chen, H.; Li, X.; Qian, P. TRIM52 inhibits japanese encephalitis virus replication by degrading the viral NS2A. Sci. Rep. 2016.
223. Jones, M.; Davidson, A.; Hibbert, L.; Gruenwald, P.; Schlaak, J.; Ball, S.; Foster, G.R.; Jacobs, M. Dengue virus inhibits interferon signaling by reducing stat2 expression. J. Virol. 2005, 79, 5414-5420.
224. Munoz-Jordan, J.L.; Sanchez-Burgos, G.G.; Laurent-Rolle, M.; Garcia-Sastre, A. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 2003, 100, 14333-14338.
225. Tu, Y.C.; Yu, C.Y.; Liang, J.J.; Lin, E.; Liao, C.L.; Lin, Y.L. Blocking double-stranded RNA-activated protein kinase PKR by japanese encephalitis virus nonstructural protein 2a. J. Virol. 2012, 86, 10347-10358.
226. Liu, B.; Li, N.L.; Wang, J.; Shi, P.Y.; Wang, T.; Miller, M.A.; Li, K. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus. J. Virol. 2014, 88, 13821-13835.
227. Jiang, D.; Guo, H.; Xu, C.; Chang, J.; Gu, B.; Wang, L.; Block, T.M.; Guo, J.T. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J. Virol. 2008, 82, 1665-1678.
228. Wang, J.; Liu, B.; Wang, N.; Lee, Y.M.; Liu, C.; Li, K. TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection. J. Virol. 2011, 85, 3733-3745.
229. Robertson, S.J.; Lubick, K.J.; Freedman, B.A.; Carmody, A.B.; Best, S.M. Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function. J. Immunol. 2014, 192, 2744-2755.
230. Diamond, M.S. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses. J. Interferon Cytokine Res. 2009, 29, 521-530.
231. Best, S.M.; Morris, K.L.; Shannon, J.G.; Robertson, S.J.; Mitzel, D.N.; Park, G.S.; Boer, E.; Wolfinbarger, J.B.; Bloom, M.E. Inhibition of interferon-stimulated jak-stat signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J. Virol. 2005, 79, 12828-12839.
232. Taylor, R.T.; Lubick, K.J.; Robertson, S.J.; Broughton, J.P.; Bloom, M.E.; Bresnahan, W.A.; Best, S.M. TRIM79, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 2011, 10, 185-196.
233. Li, M.M.; Lau, Z.; Cheung, P.; Aguilar, E.G.; Schneider, W.M.; Bozzacco, L.; Molina, H.; Buehler, E.; Takaoka, A.; Rice, C.M. TRIM25 enhances the antiviral action of zinc-finger antiviral protein (zap). PLoS Pathog. 2017, 13, e1006145.
234. Maroui, M.A.; Pampin, M.; Chelbi-Alix, M.K. Promyelocytic leukemia isoform iv confers resistance to encephalomyocarditis virus via the sequestration of 3d polymerase in nuclear bodies. J. Virol. 2011, 85, 13164-13173.
235. Zhang, S.; Guo, J.-T.; Wu, J.Z.; Yang, G. Identification and characterization of multiple trim proteins that inhibit hepatitis B virus transcription. PLoS ONE 2013, 8, e70001.
236. Hattlmann, C.J.; Kelly, J.N.; Barr, S.D. TRIM22: A diverse and dynamic antiviral protein. Mol. Biol. Int. 2012, 2012, 153415.
237. Gao, B.; Duan, Z.; Xu, W.; Xiong, S. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located ring domain. Hepatology 2009, 50, 424-433.
238. Huang, H.-H.; Chen, C.-S.; Wang, W.-H.; Hsu, S.-W.; Tsai, H.-H.; Liu, S.-T.; Chang, L.-K. TRIM5 promotes ubiquitination of RTA from epstein-barr virus to attenuate lytic progression. Front. Microbiol. 2016, 7.
239. Scherer, M.; Stamminger, T. Emerging role of PML nuclear bodies in innate immune signaling. J. Virol. 2016, 90, 5850-5854.
240. Ludwig, S.; Wolff, T. Influenza A virus TRIMs the type I interferon response. Cell Host Microbe 2009, 5, 420-421.
241. Heikel, G.; Choudhury, N.R.; Michlewski, G. The role of TRIM25 in development, disease and RNA metabolism. Biochem. Soc. Trans. 2016, 44, 1045-1050.
242. Rudnicka, A.; Yamauchi, Y. Ubiquitin in influenza virus entry and innate immunity. Viruses 2016, 8, 293.
243. Wei, Y.; Zhou, H.; Wang, A.; Sun, L.; Wang, M.; Jia, R.; Zhu, D.; Liu, M.; Yang, Q.; Wu, Y. TRIM25 identification in the chinese goose: Gene structure, tissue expression profiles, and antiviral immune responses in vivo and in vitro. BioMed Res. Int. 2016, 2016.
244. Sanchez-Aparicio, M.T.; Ayllon, J.; Leo-Macias, A.; Wolff, T.; Garcia-Sastre, A. Subcellular localizations of RIG-I, TRIM25, and MAVS complexes. J. Virol. 2017.
245. Hu, Y.; Li, W.; Gao, T.; Cui, Y.; Jin, Y.; Li, P.; Ma, Q.; Liu, X.; Cao, C. The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I interferon production by interfering with TRIM25-mediated RIG-I ubiquitination. J. Virol. 2017, 91, e02143-16.
246. Santiago, F.W.; Covaleda, L.M.; Sanchez-Aparicio, M.T.; Silvas, J.A.; Diaz-Vizarreta, A.C.; Patel, J.R.; Popov, V.; Yu, X.J.; Garcia-Sastre, A.; Aguilar, P.V. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J. Virol. 2014, 88, 4572-4585.
247. Fatima, M.; Kumari, R.; Schwamborn, J.C.; Mahadevan, A.; Shankar, S.; Raja, R.; Seth, P. Tripartite containing motif 32 modulates proliferation of human neural precursor cells in HIV-1 neurodegeneration. Cell Death Differ. 2016, 23, 776-786.
248. Ashour, J.; Laurent-Rolle, M.; Shi, P.Y.; Garcia-Sastre, A. Ns5 of dengue virus mediates STAT2 binding and degradation. J. Virol. 2009, 83, 5408-5418.
249. Morrison, J.; Laurent-Rolle, M.; Maestre, A.M.; Rajsbaum, R.; Pisanelli, G.; Simon, V.; Mulder, L.C.; Fernandez-Sesma, A.; Garcia-Sastre, A. Dengue virus co-opts ubr4 to degrade Stat2 and antagonize type I interferon signaling. PLoS Pathog. 2013, 9, e1003265.
250. Tasaki, T.; Mulder, L.C.; Iwamatsu, A.; Lee, M.J.; Davydov, I.V.; Varshavsky, A.; Muesing, M.; Kwon, Y.T. A family of mammalian E3 ubiquitin ligases that contain the ubr box motif and recognize N-degrons. Mol. Cell Biol. 2005, 25, 7120-7136.
251. Eaton, B.T.; Broder, C.C.; Middleton, D.; Wang, L.F. Hendra and nipah viruses: Different and dangerous. Nat. Rev. Microbiol. 2006, 4, 23-35.
252. Pentecost, M.; Vashisht, A.A.; Lester, T.; Voros, T.; Beaty, S.M.; Park, A.; Wang, Y.E.; Yun, T.E.; Freiberg, A.N.; Wohlschlegel, J.A.; et al. Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among paramyxovirinae matrix proteins. PLoS Pathog. 2015, 11, e1004739.
253. Wang, Y.E.; Park, A.; Lake, M.; Pentecost, M.; Torres, B.; Yun, T.E.; Wolf, M.C.; Holbrook, M.R.; Freiberg, A.N.; Lee, B. Ubiquitin-regulated nuclear-cytoplasmic trafficking of the nipah virus matrix protein is important for viral budding. PLoS Pathog. 2010, 6, e1001186.
254. Thomas, E. Hepatitis b virus x protein: Trimming antiviral defences in hepatocytes. Gut 2017.
255. Lim, K.-H.; Park, E.-S.; Kim, D.H.; Cho, K.C.; Kim, K.P.; Park, Y.K.; Ahn, S.H.; Park, S.H.; Kim, K.-H.; Kim, C.W. Suppression of interferon-mediated anti-hbv response by single CpG methylation in the 5[prime]-utr of TRIM22. Gut 2017.
256. Li, X.; Burton, E.M.; Bhaduri-McIntosh, S. Chloroquine triggers epstein-barr virus replication through phosphorylation of kap1/TRIM28 in burkitt lymphoma cells. PLoS Pathog. 2017, 13, e1006249.
257. Zhao, N.; Wang, X.-L.; Gu, Q.-H.; Huang, F.; Zheng, W.; Li, Z.-W. Tripartite motif-containing 22 gene-364t/c polymorphism associated with hepatitis B virus infection in chinese han population. Hepat. Mon. 2014.
258. Conwell, S.E.; White, A.E.; Harper, J.W.; Knipe, D.M. Identification of TRIM27 as a novel degradation target of herpes simplex virus 1 icp0. J. Virol. 2015, 89, 220-229.
259. Bharaj, P.; Atkins, C.; Luthra, P.; Giraldo, M.I.; Dawes, B.E.; Miorin, L.; Johnson, J.R.; Krogan, N.J.; Basler, C.F.; Freiberg, A.N.; et al. The host E3-ubiquitin ligase TRIM6 ubiquitinates the ebola virus VP35 protein and promotes virus replication. J. Virol. 2017, 91, e00833-17.
260. Cardenas, W.B.; Loo, Y.M.; Gale, M., Jr.; Hartman, A.L.; Kimberlin, C.R.; Martinez-Sobrido, L.; Saphire, E.O.; Basler, C.F. Ebola virus VP35 protein binds double-stranded RNA and inhibits / interferon production induced by RIG-I signaling. J. Virol. 2006, 80, 5168-5178.
261. Luthra, P.; Ramanan, P.; Mire, C.E.; Weisend, C.; Tsuda, Y.; Yen, B.; Liu, G.; Leung, D.W.; Geisbert, T.W.; Ebihara, H.; et al. Mutual antagonism between the ebola virus VP35 protein and the RIG-I activator pact determines infection outcome. Cell Host Microbe 2013, 14, 74-84.
262. Prins, K.C.; Cardenas, W.B.; Basler, C.F. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases ikkepsilon and TBK-1. J. Virol. 2009, 83, 3069-3077.
263. Muhlberger, E. Filovirus replication and transcription. Future Virol. 2007, 2, 205-215.
264. Yang, Z.; Klionsky, D.J. Eaten alive: A history of macroautophagy. Nat. Cell Biol. 2010, 12, 814-822.
265. Deretic, V.; Levine, B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 2009, 5, 527-549.
266. Mizushima, N.; Levine, B.; Cuervo, A.M.; Klionsky, D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451, 1069-1075.
267. Deretic, V. Autophagy in leukocytes and other cells: Mechanisms, subsystem organization, selectivity, and links to innate immunity. J. Leukoc. Biol. 2016, 100, 969-978.
268. Kimura, T.; Jain, A.; Choi, S.W.; Mandell, M.A.; Johansen, T.; Deretic, V. TRIM-directed selective autophagy regulates immune activation. Autophagy 2017, 13, 989-990.
269. Mandell, M.A.; Jain, A.; Arko-Mensah, J.; Chauhan, S.; Kimura, T.; Dinkins, C.; Silvestri, G.; Munch, J.; Kirchhoff, F.; Simonsen, A.; et al. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev. Cell 2014, 30, 394-409.
270. Mandell, M.A.; Kimura, T.; Jain, A.; Johansen, T.; Deretic, V. TRIM proteins regulate autophagy: TRIM5 is a selective autophagy receptor mediating HIV-1 restriction. Autophagy 2014, 10, 2387-2388.
271. Stremlau, M.; Perron, M.; Lee, M.; Li, Y.; Song, B.; Javanbakht, H.; Diaz-Griffero, F.; Anderson, D.J.; Sundquist, W.I.; Sodroski, J. Specific recognition and accelerated uncoating of retroviral capsids by the trim5 restriction factor. Proc. Natl. Acad. Sci. USA 2006, 103, 5514-5519.
272. Napolitano, L.M.; Jaffray, E.G.; Hay, R.T.; Meroni, G. Functional interactions between ubiquitin E2 enzymes and TRIM proteins. Biochem. J. 2011, 434, 309-319.